Coming in December 2012
Reach thousands of the most influential decision makers in the pharmaceutical and biopharmaceutical industries!
Inside Outsourcing - a special annual issue on outsourcing strategies - is brought to you buy the editorial team of the most respected magazines serving the pharmaceutical and biopharmaceutical industries.
AD RESERVATION DEADLINE: NOVEMBER 7, 2012
Contact your sales representative to book a premium position today!
Bonus Distribution 2012Editorial Highlights 2012Rates 2012Circulation 2012Coming in December 2012
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.